Protagonist Therapeutics Inc (PTGX)
41.49
+1.95
(+4.93%)
USD |
NASDAQ |
Dec 20, 16:00
41.51
+0.02
(+0.05%)
After-Hours: 20:00
Protagonist Therapeutics Profit Margin (Quarterly): -710.4% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Assembly Biosciences Inc | -140.4% |
| Precision BioSciences Inc | -2.85K% |
| Entrada Therapeutics Inc | -71.70% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 37.59% |
| Return on Assets | 33.69% |
| Return on Invested Capital | 37.59% |
| Operating Margin (Quarterly) | -886.7% |
| Return on Net Operating Assets | 231.6% |